INTRODUCTION
Iduronate-2-sulphatase (12S; EC 3.1.6.13) is one of the lysosomal enzymes involved in the degradation of the glycosaminoglycans heparan sulphate (HS) and dermatan sulphate (DS). A deficiency of this enzyme activity results in the lysosomal storage disorder mucopolysaccharidosis type II (MPS II), also known as Hunter syndrome (McKusick and Neufeld, 1983) , and is inherited as an X-chromosome-linked recessive trait. The clinical presentation of this disorder is characterized by skeletal dysmorphism, coarse facies, hepatosplenomegaly and, in its severe form, mental retardation and death by the age of 15 years (McKusick and Neufeld, 1983) . MPS II patients store and excrete excessive amounts of partially degraded HS and DS fragments. Although clinically severe MPS II involves central-nervous-system (CNS) pathology, enzyme-replacement therapy is likely to be valuable in at least treating the somatic symptoms of the disease. It is also possible that the blood/brain barrier will be able to transport mannose 6-phosphorylated or suitably engineered 12S carrying alternative transport signals. Enzyme-replacement therapy for MPS II and other lysosomal storage disorders (LSDs) that have CNS involvement is therefore worthy of investigation.
Human 12S has been purified from liver in small quantities (Bielicki et al., 1990) . As a source of enzyme, however, liver and other tissues are limited by the extreme low abundance of 12S, which results in a low yield of purified enzyme, for example, less than 10 lg of I2S/kg of liver. Recombinant DNA technology has been used successfully to express full-length N-acetylgalactosamine-4-sulphatase (4S) cDNA in CHO (Chinesehamster ovary)-K1 cells with yields of several mg of enzyme/litre of culture medium (Anson et al., 1992) . The 'high uptake' conditioned medium was identified. Enzyme secreted from this cell line grown in the presence of NH4C1 was shown to be endocytosed into MPS II fibroblasts via the mannose 6-phosphate receptor and localized to the lysosomal compartment, resulting in correction of the storage phenotype of these cells. Milligram quantities of the recombinant 12S were purified, and the enzyme was shown to have a pH optimum and kinetic parameters similar to those for the mature form of 12S purified from human liver. The recombinant 12S had a molecular mass of approx. 90 kDa; this was reduced to 60 kDa by endoglycosidase treatment.
precursor form of 4S was observed to be similar to endogenous 4S with respect to its catalytic properties in vitro and its biological properties in vivo. In order to evaluate enzyme-replacement therapy for MPS II and to investigate possible transport mechanisms for lysosomal enzymes across the blood/brain barrier, we have expressed a full-length 12S cDNA in CHO-K1 cells and purified the secreted form of the enzyme from conditioned medium. Although the recombinant 12S (rI2S) has a larger molecular mass than that reported for 12S from human liver (Bielicki et al., 1990) , both were shown to have similar pH optimum and catalytic properties. The rI2S was efficiently endocytosed by MPS II fibroblasts and subsequently localized to lysosomes, resulting in correction of the enzymatic defect and initiation of the degradation of stored 35S-labelled glycosaminoglycans. The recombinant enzyme is therefore suitable for initial evaluation of enzyme-replacement therapy in MPS II as well as providing a source of material for production of antibodies and for biochemical and physical studies. 
MATERIALS AND METHODS

DNA manipulation and recombinant plasmids
All DNA preparation, modification and cloning procedures were done using standard techniques (Ausubel et al., 1989) . The 12S cDNA clone pBl2Sc17 contains bp 107 (Notl restriction-enzyme site) to bp 1870 (BstXI restriction-enzyme site) of the 12S cDNA sequence presented in Figure 1 of Wilson et al. (1990) Culture of fibroblasts Human diploid fibroblasts were established from skin biopsies submitted to this hospital for diagnosis (Hopwood et al., 1982) . Cell lines were maintained according to established procedures in BME, 10% (v/v) FCS and antibiotics unless otherwise stated. The two MPS II skin fibroblast cell lines used in the present study (SF-635 and SF-1779) , 1990) . Protein was determined by the method of Lowry et al.
(1951), with BSA as standard.
fl-Hexosaminidase
The fluorogenic substrate 4-methylumbelliferyl 2-acetamido-2-deoxy-,8-D-glucopyranoside was used to measure ,Bhexosaminidase activity (Leaback and Walker, 1961) .
Correction of MPS II fibroblasts
For these experiments r12S was obtained from CHOEFI2S-9 cells cultured in CHO-SFM medium supplemented with 10 mM NH4C1 and antibiotics. The medium was concentrated 10-fold by ultrafiltration and was shown to contain rI2S with activity of 2.75 x 106 pmol/min per ml (133 ,sg of 12S/ml). Fibroblasts from a normal individual (SF-3409) and from two MPS II patients (SF-635 and SF-1779) were grown to confluency in 25 cm2 flasks and radiolabelled with Na235SO4 as previously described (Anson et al., 1992 ). The labelled cells were then exposed to r12S
(5 x 104 pmol/min per ml) for 72 h. After harvesting the cells by trypsin treatment and washing by centrifugation/resuspension in PBS, the cell pellet was resuspended in 100 ,ul of 20 mM Tris/HCl (pH 7.0)/0.5 M NaCl, and the cell lysates prepared as described under 'Determination of 12S expression' above. The cell extracts were analysed for 12S activity, total protein, /3-hexosaminidase activity and radioactivity.
Endocytosis of rl2S SF-1779 fibroblasts were plated in 20 wells (3.83 cm2) and allowed to reach confluency. Wells 1-4 were untreated controls. To each of wells 5-12 and 13-20 was added 1.0 ml of medium containing rI2S at 5 x 104 and 5 x I03 pmol/min per ml respectively. In addition the medium in wells 9-12 and 17-20 was made 5 mM mannose 6-phosphate. The cells were then incubated for 6 h, after which time they were rinsed with medium and fresh medium added. The cells were incubated overnight and then harvested, washed and lysed as described above. The cell lysates were dialysed against 5 mM sodium acetate, pH 4.0, for 16 h at 4°C and then analysed for 12S activity and total protein.
Subcellular fractionation SF-635 fibroblasts were grown to confluency in 75 cm2 flasks and then exposed to medium supplemented with 5 x 104pmol of r12S/min per ml. The cells were incubated for 72 h, then harvested and fractionated on Percoll density gradients as described in Anson et al. (1992) . The resulting gradient was collected in 1.0 ml fractions by bottom puncture and the fractions analysed for 12S and,3-hexosaminidase activity.
Large-scale production of rl2S CHOEFL2S-9 cells were inoculated into two two-layer cell factories (Nunc; 1200 cm2) in Ham's F12, 10 % (v/v) FCS (v/v) in glycerol, 0.1 mM in DTE and 3 mM in NaN3. The column was further eluted with 100 ml of 15 mM 3,3-dimethyl glutarate (pH 6.0)/0.5 M NaCl/10% (v/v) glycerol/O.l mM DTE/3 mM NaN3 (buffer B). The rI2S eluted in buffer B was applied at a flow rate of 1.0 ml/min to a Blue A-agarose column (6 cm x 0.7 cm), also equilibrated in buffer B. The rI2S activity from this step was applied in 1.0 ml volumes to an LKB Ultrachrom GTi f.p.l.c. system with a TSK G3000SW Ultrapac column (30 cm x 0.8 cm) equilibrated and eluted in buffer B at a flow rate of 0.5 ml/min and pressure of 150 kPa. Fractions containing 12S activity were pooled and analysed under denaturing and non-denaturing conditions by SDS/PAGE (1000 acrylamide) to estimate apparent subunit size. Gels were stained with either Gradipure Colloidal Electrophoresis Gel Stain (Gradipure, Pyrmont, N.S.W., Australia) or silver-stained by the method of Merril et al. (1981) . Native molecular mass was determined using an f.p.l.c. system described elsewhere (Bielicki et al., 1990) . Kinetic (Ki, Vmax and pH optima) and inhibition data were obtained as described previously (Bielicki et al., 1990) .
Endoglycosidase F treatment of rl2S
To two identical 60,ul samples, each containing 2.5 ,ug of rI2S, was added an equal volume of buffer containing 100 mM sodium phosphate (pH 6.1)/50 mM EDTA/1 % (v/v) Nonidet P40/ 0.1 % (v/v) SDS/1 % (v/v) 2-mercaptoethanol. After boiling both samples for 5 min, to one was added 1 unit and to the other 5 units of endoglycosidase. Both samples were incubated for 17 h at 37 'C. A control sample was untreated but stored in similar buffer conditions at 4 'C. Bromophenol Blue was added to each sample before analysis by SDS/PAGE. Molecular-mass standards were subjected to SDS/PAGE in the same buffer as the enzyme samples.
RESULTS AND DISCUSSION Construction of 12S expression vectors
An initial expression construct containing the 12S cDNA from pBl2Sc17 cloned into pRSVN.08 expressed 12S at very low levels when introduced into CHO-K I cells. A chimaeric 12S cDNA was then made by replacing the 5' non-coding sequence of the 12S cDNA with 45 bp of the rat preproinsulin leader sequence (Figure 1 ) as an analogous chimaeric N-acetylgalactosamine-4-sulphatase cDNA construct resulted in the expression of high levels of enzyme activity in the same system (Anson et al., 1992) . Briefly the sequence shown in Figure 1 was Large-scale production of r12S
Conditioned serum-free Ham's F12 medium containing NH4CI
was collected as described in the Materials and methods section. Enzyme was collected in this manner to facilitate purification by minimizing total protein in medium. As prolonged exposure to this medium resulted in loss of cell viability, the cells were cycled in Ham's F12 with 100 , (v/v) FCS to allow recovery. A total of 1 litre of serum-free medium, containing approx. 11 mg of r12S, was collected in this manner. The rI2S bound very tightly to PBE94 medium and was not eluted in significant amounts during Polybuffer elution (less than 10 %0 of the total enzyme recovered from this column was eluted with polybuffer; pool A; Figure 2a) . Most of the rI2S (pool B; Figure 2a ) had a pl of < 4.0 and required NaCl for elution.
Enzyme was eluted in buffer B in concentrated form (essentially in one 10 ml fraction). This permitted direct application to Blue A-agarose. Although the rI2S did not bind to this matrix, it was a necessary step to remove some minor contaminating proteins which were observed after f.p.l.c. when the enzyme from the chromatofocusing step was applied directly to f.p.l.c. Recovery of activity from Blue A-agarose was 800%. The final step in the purification (f.p.l.c.) resulted in an overall recovery of greater than 150% activity. The estimated native molecular mass on f.p.l.c. was 90 kDa. A single diffuse protein band of 80-92 kDa was observed when a sample from the f.p.l.c. step was subjected to SDS/PAGE (Figure 3 ). This diffuse band was observed on SDS/PAGE run under reducing or non-reducing conditions, indicative of a single subunit species with no disulphide bonding. Correlation of the protein species observed as a diffuse band on SDS/PAGE with I2S activity was demonstrated by PAGE run under non-reducing conditions by the method of Laemmli (1970) , but with the modification that SDS was omitted from all buffers. Identical amounts of enzyme were applied to two lanes of the gel. One lane was stained for protein and, as with SDS/PAGE, a single diffuse band was observed. The other was cut into 2 mm slices and each slice was incubated in four times its volume of assay mix at 37°C overnight. When corrected for the swelling which occurred during the staining procedure, the position of the diffuse band corresponded to that of 12S activity in the lane that was sliced and assayed (results not shown).
The molecular size of 12S (after cleavage of the signal peptide) estimated from cDNA sequence data indicated a maximum of 58 kDa with seven potential glycosylation sites (Wilson et al., 1990) . The mature or processed forms of 12S had various molecular sizes depending on the column matrix used. The native molecular size varied from 42 to 65 kDa, while, on a denaturing SDS/PAGE, two polypeptide bands of 43 kDa and 14.4 kDa were consistently observed (Bielicki et al., 1990) . The recombinant form of 12S had a markedly larger molecular size (80-90 kDa; Figure 3 ) than predicted. Figure 4 SOS/PAGE of rl2S after treatment with endoglycosidase F rl2S was treated with endoglycosidase F, reduced, electrophoresed and stained with Gradipure Colloidal Gel Stain as described in the Materials and methods section. Lane 1 contains untreated rl2S, and lanes 2 and 3 contain rl2S treated with 1 and 5 units of endoglycosidase F respectively. Lane 4 contains molecular-mass (M) standards.
a decrease irn molecular size (70-80 kDa). However, the enzyme still migrated as a diffuse band on SDS/PAGE (Figure 4 ; lane 2). Lane 3, which shows the result of treatment with a fivefold greater concentration of endoglycosidase F demonstrates the presence of a tightly staining 60 kDa protein band with a diffuse band above it (62-68 kDa). Other bands are due to endoglycosidase F. We suggest that the 60 kDa band is the end product of the deglycosylation of rI2S by endoglycosidase F and that the diffuse bands in both lanes are the result of incomplete digestion. Endoglycosidase F cleaves the glycosidic bond between Nacetylglucosamine (GlcNAc) residues of the chitobiose core in the N-linked carbohydrate chains, resulting in one GlcNAc residue remaining linked to asparagine. This would account for approx. 1540 kDa due to carbohydrate if all seven of the glycosylation sites were utilized, and may therefore account for the molecular size of 12S after endoglycosidase F treatment as being 60 kDa rather than 58 kDa. 
Demonstration of correction of MPS 11 fibroblasts
Fibroblasts from patients with MPS I1 store undegraded HS and DS fragments. This storage is reflected in the accumulation of labelled material when the cells are metabolically labelled with Na235SO4. Supplementing culture medium with r12S at 5 x 104 pmol/min per ml resulted in clearance of this stored product to levels comparable with those seen in control fibroblasts (Table 3) and to levels of 12S activity 40-80-fold above normal in SF-1779 and SF-635 respectively. The activity of a second lysosomal enzyme, ,-hexosaminidase, was not affected by endocytosis of 12S (Table 3) .
To test whether endocytosis of the rI2S occurs via the mannose 6-phosphate receptor, MPS II cells (SF-1779) were cultured in medium supplemented with r12S at 5 x 104 and 5 x 103 pmol/min per ml in the presence or absence of 5 mM mannose 6-phosphate. Inhibition of the uptake of 12S activity by mannose 6-phosphate at both doses of enzyme confirmed that uptake is mediated via the mannose 6-phosphate receptor. The degree of inhibition was dependent on the concentration of r12S. However, as the SF-1 779 SF-1779 + rl2S* SF-1779 + rl2S* + M-6-P SF-1779 + rl2St SF-1779 + rl2St + M-6-P MPS 11 fibroblasts were exposed to rU2S and cell lysates were fractionated on Percoll gradients as described in the Materials and methods section. Fractions were assayed for 12S (@) and /J-hexosaminidase activity (0).
concentration of 12S in cell lysates was the same, regardless of the dose, this implied that the rate-limiting factor for uptake was the availability of mannose 6-phosphate receptor ( 
